FUSION

LIVE

Serial Number

90447045

Owner

Fusion Pharmaceuticals Inc.

Attorney

Jonathan M. Gelchinsky

First Use Date

Mar 27, 2023

Filing Date

Jan 4, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FUSION Trademark

Serial Number: 90447045 • Registration: 7108424

FUSION is a trademark filed by Fusion Pharmaceuticals Inc. on January 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Fusion Pharmaceuticals Inc. (4 trademarks)

Hamilton, Ontario L8P0A6 , CA

Entity Type: 03

Legal Representation

Attorney of Record

Jonathan M. Gelchinsky

1,778 trademarks filed View all →

Correspondence Address

Jonathan M. Gelchinsky PIERCE ATWOOD LLP

254 COMMERCIAL STREET

PORTLAND

ME 04101

United States

Trademark Details

Filing Date

January 4, 2021

Registration Date

July 11, 2023

First Use Anywhere

March 27, 2023

First Use in Commerce

March 27, 2023

Published for Opposition

September 13, 2022

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 11, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 11, 2023 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 9, 2023 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 8, 2023 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jun 6, 2023 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 6, 2023 AITU

USE AMENDMENT FILED

May 15, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

May 15, 2023 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 4, 2023 EXRA

SOU EXTENSION 1 GRANTED

May 2, 2023 EX1G

SOU EXTENSION 1 FILED

May 2, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

May 2, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 8, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 13, 2022 NPUB

PUBLISHED FOR OPPOSITION

Sep 13, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 24, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 6, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 8, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 8, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 8, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 10, 2022 GNRN

NON-FINAL ACTION E-MAILED

Jan 10, 2022 GNRT

NON-FINAL ACTION WRITTEN

Jan 10, 2022 CNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 22, 2021 GNRN

NON-FINAL ACTION E-MAILED

Jul 22, 2021 GNRT

NON-FINAL ACTION WRITTEN

Jul 22, 2021 CNRT

ASSIGNED TO EXAMINER

Jul 12, 2021 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 2, 2021 NWOS

NEW APPLICATION ENTERED

Jan 7, 2021 NWAP

Related Trademarks

More from this Owner

FUSION PHARMACEUTICALS INC.

More in Same Class